Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) EBT Margin (2016 - 2025)

iBio (IBIO) has disclosed EBT Margin for 16 consecutive years, with 5720.0% as the latest value for Q3 2025.

  • On a quarterly basis, EBT Margin changed N/A to 5720.0% in Q3 2025 year-over-year; TTM through Dec 2025 was 8245.67%, a 418327.0% decrease, with the full-year FY2025 number at 4594.25%, up 271375.0% from a year prior.
  • EBT Margin was 5720.0% for Q3 2025 at iBio, down from 2581.5% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 374.89% in Q1 2022 to a low of 10148.0% in Q3 2023.
  • A 5-year average of 3630.66% and a median of 2182.0% in 2024 define the central range for EBT Margin.
  • Biggest YoY gain for EBT Margin was 388848bps in 2021; the steepest drop was -506363bps in 2021.
  • iBio's EBT Margin stood at 6901.19% in 2021, then soared by 95bps to 374.89% in 2022, then plummeted by -2607bps to 10148.0% in 2023, then skyrocketed by 78bps to 2182.0% in 2024, then plummeted by -162bps to 5720.0% in 2025.
  • Per Business Quant, the three most recent readings for IBIO's EBT Margin are 5720.0% (Q3 2025), 2581.5% (Q2 2025), and 2182.0% (Q4 2024).